Initial evaluation human monoclonal anti-lipid antibody patients sepsis syndrome human monoclonal immunoglobulin antibody lipid domain endotoxin septic patients safety pharmacokinetics immunogenicity antibody Thirty-four patients single infusion mg mg mg days treatment serum levels infusion infusion radiometric assay one-compartment pharmacokinetic model fit serum levels changes level time dose group mean SEM apparent volume distribution ml/kg mean serum clearance ml/kg.h mean serum half-life mean serum level hour dose micrograms/ml mean concentration micrograms/ml dose presence Gram-negative bacterial infection volume distribution serum clearance adverse reactions antibodies patient data pharmacokinetics one-compartment pharmacokinetic model safe nonimmunogenic patients sepsis 